STUDYING THE BIOLOGICAL PROPERTIES OF BACTERIOPHAGES AGAINST ESKAPE PATHOGENS

Bacterial infections caused by multidrug-resistant (MDR) strains are among the most dangerous threats to global public health. The highest number of resistance cases is detected among the so-called ESKAPE pathogens (from the initials of Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.). These bacteria cause life-threatening nosocomial infections, especially in individuals with weakened immune systems and chronic diseases. The article discusses the rationale for phage therapy, clinical problems, and proposes phage therapy as an effective means against ESKAPE pathogens. It characterizes some of their biological properties (effect of high temperature, resistance to chloroform exposure, and the impact of pH changes on bacteriophage activity). High temperature was studied as a physical factor, and chloroform exposure as a chemical factor affecting bacteriophages. The study found that heating phages for 30 minutes at 60°C did not affect their activity. They maintained activity within a pH range of 7.0 to 7.5 and were resistant to chloroform exposure for 40 minutes. It should be noted that the alkaline environment of the buffer solution slightly affected the activity of the studied bacteriophages, while the acidic environment had a more significant impact on reducing their infectivity.

1. Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K., Wertheim, H. F., Sumpradit, N., ... & others. (2013). Antibiotic resistance – the need for global solutions. The Lancet Infectious Diseases, 13(12), 1057–1098. https://doi.org/10.1016/S1473-3099(13)70318-9.

2. Ayukekbong, J. A., Ntemgwa, M., & Atabe, A. N. (2017). The threat of antimicrobial resistance in developing countries: Causes and control strategies. Antimicrob Resist Infection Control, 15(6), 47. https://doi.org/10.1186/s13756-017-0208-x.

3. Bloom, D. E., & Cadarette, D. (2019). Infectious disease threats in the twenty-first century: Strengthening the global response. Frontiers in Immunology, 10, 549. https://doi.org/10.3389/fimmu.2019.00549.

4. Collignon, P. J., Conly, J. M., Andremont, A., McEwen, S. A., Aidara-Kane, A., ... & others. (2016). World Health Organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies to control antimicrobial resistance from food animal production. Clinical Infectious Diseases, 63(8), 1087–1093. https://doi.org/10.1093/cid/ciw475.

5. Adeniji, F. (2018). Global analysis of strategies to tackle antimicrobial resistance. International Journal of Pharmacy Practice, 26(1), 85–89. https://doi.org/10.1111/ijpp.12365.

6. Veeraraghavan, B., & Walia, K. (2019). Antimicrobial susceptibility profile & resistance mechanisms of Global Antimicrobial Resistance Surveillance System (GLASS) priority pathogens from India. Indian Journal of Medical Research, 149(2), 87–96. https://doi.org/10.4103/ijmr.IJMR_214_18.

7. Arepyeva, M. A., Kolbin, A. S., Sidorenko, S. V., Lawson, R., Kurylev, A. A., Balykina, Y. E., ... & others. (2017). A mathematical model for predicting the development of bacterial resistance based on the relationship between the level of antimicrobial resistance and the volume of antibiotic consumption. Journal of Global Antimicrobial Resistance, 8, 148–156. https://doi.org/10.1016/j.jgar.2016.11.010.

8. Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019). Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A review. Frontiers in Microbiology, 10, 539. https://doi.org/10.3389/fmicb.2019.00539.

9. Santajit, S., & Indrawattana, N. (2016). Mechanisms of antimicrobial resistance in ESKAPE pathogens. BioMed Research International, (2), 1–8. https://doi.org/10.1155/2016/2475067.

10. M100 Performance Standards for Antimicrobial Susceptibility Testing. (2019). An informational supplement for global application developed through the Clinical and Laboratory Standards Institute consensus process (29th ed.).

11. Djioev, Y. P., Zlobin, V. I., Salovarova, V. P., Stepanenko, L. A., Reva, O. N., Borisенко, A. Y., Peretolchina, N. P., & Bukin, Y. S. (2019). Analysis of the problem of "superbugs" and modern approaches to solving it. Izvestiya Vuzov. Applied Chemistry and Biotechnology, 9(4).

12. Adeniji, F. (2018). Global analysis of strategies to tackle antimicrobial resistance. International Journal of Pharmacy Practice, 26(1), 85–89. https://doi.org/10.1111/ijpp.12365.

13. Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019). Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A review. Frontiers in Microbiology, 10, 539. https://doi.org/10.3389/fmicb.2019.00539.

14. Aslam, S., Lampley, E., Wooten, D., Karris, M., Benson, C., Strathdee, S., ... & others. (2020). Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States. Open Forum Infectious Diseases, 7, ofaa 389. https://doi.org/10.1093/ofid/ofaa389.